Skip to main content
Journal cover image

Efficacy and safety of nivolumab in combination with docetaxel in men with metastatic castration-resistant prostate cancer in CheckMate 9KD

Publication ,  Conference
Fizazi, K; Gonzalez Mella, P; Castellano, D; Minatta, N; Kalebasty, AR; Shaffer, D; Vazquez Limon, JC; Armstrong, AJ; Sanchez Lopez, HM; Saci, A ...
Published in: ANNALS OF ONCOLOGY
October 1, 2019

Duke Scholars

Published In

ANNALS OF ONCOLOGY

EISSN

1569-8041

ISSN

0923-7534

Publication Date

October 1, 2019

Volume

30

Location

Barcelona, SPAIN

Publisher

OXFORD UNIV PRESS

Conference Name

44th Congress of the European-Society-for-Medical-Oncology (ESMO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Fizazi, K., Gonzalez Mella, P., Castellano, D., Minatta, N., Kalebasty, A. R., Shaffer, D., … Drake, C. (2019). Efficacy and safety of nivolumab in combination with docetaxel in men with metastatic castration-resistant prostate cancer in CheckMate 9KD. In ANNALS OF ONCOLOGY (Vol. 30). Barcelona, SPAIN: OXFORD UNIV PRESS.
Fizazi, K., P. Gonzalez Mella, D. Castellano, N. Minatta, A Rezazadeh Kalebasty, D. Shaffer, J. C. Vazquez Limon, et al. “Efficacy and safety of nivolumab in combination with docetaxel in men with metastatic castration-resistant prostate cancer in CheckMate 9KD.” In ANNALS OF ONCOLOGY, Vol. 30. OXFORD UNIV PRESS, 2019.
Fizazi K, Gonzalez Mella P, Castellano D, Minatta N, Kalebasty AR, Shaffer D, et al. Efficacy and safety of nivolumab in combination with docetaxel in men with metastatic castration-resistant prostate cancer in CheckMate 9KD. In: ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2019.
Fizazi K, Gonzalez Mella P, Castellano D, Minatta N, Kalebasty AR, Shaffer D, Vazquez Limon JC, Armstrong AJ, Sanchez Lopez HM, Sharkey B, Saci A, Li J, Wang X, Ciprotti M, Sathyanarayana P, Saad F, Petrylak DP, Retz MM, Pachynski RK, Drake C. Efficacy and safety of nivolumab in combination with docetaxel in men with metastatic castration-resistant prostate cancer in CheckMate 9KD. ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2019.
Journal cover image

Published In

ANNALS OF ONCOLOGY

EISSN

1569-8041

ISSN

0923-7534

Publication Date

October 1, 2019

Volume

30

Location

Barcelona, SPAIN

Publisher

OXFORD UNIV PRESS

Conference Name

44th Congress of the European-Society-for-Medical-Oncology (ESMO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis